INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2011

In a pilot study, weaning infants to highly hydrolyzed formula reduced cumulative incidence of diabetes-associated autoantibodies by ~50% up to age 10.

The TRIGR study evaluates whether weaning to an extensively hydrolyzed formula decreases the risk of type 1 diabetes later in childhood. In a pilot study, weaning to a highly hydrolyzed formula decreased the cumulative incidence of one or more diabetes-associated autoantibodies by ≈ 50% by mean age 4.7 years, confirmed in follow-up to 10 years of age. The full-scale trial enrolled 2159 eligible infants with risk-conferring HLA genotypes across 77 centers in 15 countries to compare hydrolyzed casein with standard cow milk-based formula for 6-8 months (minimum 2 months exposure). Eighty percent of participants were exposed to the study formula, with an 87% retention rate over the first 5 years and 94% protocol compliance; the code opens in 2017.

Study type
Randomized double-blind controlled intervention trial
Who was studied
5606 recruited newborn infants with an affected family member; 2159 enrolled with risk-conferring HLA genotypes
What was measured
Risk of type 1 diabetes and diabetes-associated autoantibodies

THE PAPER

Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).

Knip M, Virtanen SM, Becker D, Dupré J, Krischer JP, Åkerblom HK, TRIGR Study Group. Am J Clin Nutr, 2011.

PubMed 21653795 ↗DOI 10.3945/ajcn.110.000711 ↗

Diabetes & blood sugar

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.